Stock Price Quote

KREBS BIOCHEMICALS & INDUSTRIES LTD.

NSE : KREBSBIOBSE : 524518ISIN CODE : INE268B01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE86.55-1.85 (-2.09 %)
PREV CLOSE ( ) 88.40
OPEN PRICE ( ) 86.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 332
TODAY'S LOW / HIGH ( )85.85 87.80
52 WK LOW / HIGH ( )60.1 110.9
NSE86.25-2.15 (-2.43 %)
PREV CLOSE( ) 88.40
OPEN PRICE ( ) 87.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2970
TODAY'S LOW / HIGH( ) 86.00 90.60
52 WK LOW / HIGH ( )60.65 111.35
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 02-12 1991
Management Info
R T Ravi - Chairman Avinash Ravi - Managing Director
Registered Office

Address Kothapalli Village,Anakapalli,Kasimkota Mandal,
Vishakhapatnam,
Andhra Pradesh-531031

Phone

Email marketing@krebsbiochem.com / investors@krebsbiochem.com

Website www.krebsbiochem.com

Registrars Details
K FIN Technologies Pvt Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

31Oct Krebs Biochemicals & Industries inform
Pursuant to Regulation 30 read with Schedule III Part A Para A of SEBI L..
28Sep Krebs Biochemicals & Industries submit
Krebs Biochemicals & Industries has informed that the Company submit..
03Sep Krebs Biochemicals & Industries inform
Pursuant to Regulation 30 read with Schedule III Part A Para A of SEBI L..
26Sep Krebs Biochemicals & Industries inform
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosur..
03Aug Krebs Biochemicals receives temporary
Krebs Biochemicals & Industries has received temporary revocation of..

Financials

in Millions
QTR Sep 20 ANNUAL 20
Net Profit-63.91-288.72
Gross Profit -63.91 -288.72
Operating Profit -30.29-182.65
Net Sales 166.94334.12

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  15383.05 (0.51%)
M.Cap ( in Cr)32687.91
Procter&Gamble Healt (BSE)
peergroup  6412.50 (1.15%)
M.Cap ( in Cr)10644.35
Astrazeneca Pharma I (BSE)
peergroup  4506.75 (0.97%)
M.Cap ( in Cr)11266.88
Solara Active Pharma (BSE)
peergroup  1156.05 (2.55%)
M.Cap ( in Cr)4151.35
Shilpa Medicare (BSE)
peergroup  461.75 (6.60%)
M.Cap ( in Cr)3764.50

Shareholding Pattern

PROMOTERS 70.05%
NON-INSTITUTION 29.94%
FI/BANKS/INSURANCE 0%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
No Data Found

About Krebs Biochemicals & Industries Ltd.

Krebs Biochemicals & Industries Ltd. was incorporated in the year 1991. Its today's share price is 86.55. Its current market capitalisation stands at Rs 169.82 Cr. In the latest quarter, company has reported Gross Sales of Rs. 334.12 Cr and Total Income of Rs.337.77 Cr. The company's management includes Satish Khivsara, Tangirala Malati, Raj Kamal Prasad Verma, GVL Prasad, EJ Babu, Manish Jain, Avinash Ravi, R T Ravi.

It is listed on the BSE with a BSE Code of 524518 , NSE with an NSE Symbol of KREBSBIO and ISIN of INE268B01013. It's Registered office is at Kothapalli Village,Anakapalli,Kasimkota MandalVishakhapatnam-531031, Andhra Pradesh. Their Registrars are ACC Ltd. It's auditors are Bhavani & Co, Pavuluri & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)